ATH 11.1% 0.4¢ alterity therapeutics limited

France clinical trial

  1. 7,425 Posts.
    lightbulb Created with Sketch. 125
    90 given drug, one brain dead, 3 critical with permanent brain damage. Terrible outcome in phase 1 trial. PBT2 is safe and that proven safety is of out most importance as Prof Shoulson and others stressed. Interesting read. Link below:

 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(11.1%)
Mkt cap ! $20.98M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $14.55K 3.241M

Buyers (Bids)

No. Vol. Price($)
62 71906262 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 32338803 25
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.